期刊语言：英语

出版地区：英国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：https://jitc.biomedcentral.com/

3、投稿网址：https://mc.manuscriptcentral.com/jitc

4、官网邮箱：info.jitc@bmj.com

5、期刊刊期：月刊，一年出版12期。

2021年8月17日星期二

投稿须知【官网信息】

Authors

The Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. It publishes articles under several sections: Basic Tumor Immunology, Clinical/Translational Cancer Immunotherapy, Immune Cell Therapies and Immune Cell Engineering, Immunotherapy Biomarkers, and Oncolytic and Local Immunotherapy. Additional information about these sections can be found here.

Benefits of Publishing in JITC

Open Access and No Copyright Transfer

All content published in JITC is freely available upon publication.

High Impact Factor

JITC increased its Impact Factor to 10.252 in October 2020. JITC’s Impact Factor places the journal in the top 3 percent of all fully open access oncology journals and ranks in the top 8 percent of all journals published in the categories of oncology and immunology.

Stringent Ethical Standards

JITC is published by BMJ, a member of the Committee on Publishing Ethics.

Visibility

JITC is featured in a number of major indexing resources, including PubMed, PubMed Central, MEDLINE, the Directory of Open Access Journals (DOAJ), Scopus, and Clarivate Analyics’ Science Citation Index Expanded (SCIE).

Editorial Policies

JITC adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. The journal follows guidance produced by bodies that include the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) and the International Committee of Medical Journal Editors (ICMJE). To view all BMJ Journal policies, please refer to the BMJ Author Hub policies page.

We take seriously all possible misconduct. If an editor, author, or reader has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behavior, they should forward their concerns to the journal. The publisher will deal with allegations appropriately.

For guidelines on policies and submissions across our journals, please click on the links below:

Manuscript Preparation

Editorial Policies

Patient Consent Forms

License Forms

Peer Review

Submission and Production Processes

……

更多详情：

https://jitc.bmj.com/pages/authors/